Trial intelligence / Profile preview

Phase 2 open-label pralatrexate in relapsed or refractory peripheral T-cell lymphoma

2006-002811-29Phase 2Completed

Sponsor

Allos Therapeutics

Start

Oct 2006

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules

Countries

1